Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Amantadine monotherapy of chronic hepatitis C patients infected with genotype lb.

Scandinavian journal of infectious diseases - 1 Jan 2000

Senturk H, Mert A, Akdogan M, Tabak F, Basaran G, Turkoglu S, Ozbay G, Badur S

Abstract excerpt

We aimed to test the efficacy of amantadine in chronic hepatitis C (CHC) patients infected with genotype b. Twenty patients completed treatment with amantadine HCl, 100 mg b.i.d., for 6 months. Non-sustained biochemical improvement was observed without loss of HCV-RNA. We conclude that amantadine monotherapy is not effective in CHC.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis C, Chronic
Share to RNA, Viral
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adolescent

Share to Amantadine

Share to Antiviral Agents

Share to Genotype

Share to Treatment Failure

Source

Identifiers

PMID: 11055673
DOI: 10.1080/003655400458965

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Amantadine monotherapy of chronic hepatitis C patients infected with genotype lb.PMID 11055673Read ↗

No beneficial effects of amantadine in treatment of chronic hepatitis C patients.Semantic proximity Read ↗

A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.Semantic proximity Read ↗

Combination therapy with interferon-alpha(2b), ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin.Semantic proximity Read ↗

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.Semantic proximity Read ↗

A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.Semantic proximity Read ↗

Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.Semantic proximity Read ↗

Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1).Semantic proximity Read ↗

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.Semantic proximity Read ↗

Investigation of viral escape mutations within HCV p7 during treatment with amantadine in patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine.Semantic proximity Read ↗

Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.